Literature DB >> 11792147

Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries.

Changyi Chen1, Brian S Conklin, Zeguang Ren, Dian-sheng Zhong.   

Abstract

BACKGROUND: Although hyperhomocysteinemia has long been recognized as an independent risk factor for vascular disease, the mechanisms of the pathogenesis of homocysteine are largely unknown. The objective of this study was to examine the effect of homocysteine on vasomotor function and endothelial integrity in intact porcine arteries.
METHODS: Pig coronary artery rings were incubated with homocysteine (10, 50, or 100 microM) for 24 h. Myograph analysis was performed with thromboxane A2 analogue U46619 for contraction and bradykinin or sodium nitroprusside for relaxation. Pig carotid arteries were perfusion-cultured in control and 50 and 100 microM homocysteine treatment groups. The diameter change was analyzed in response to norepinephrine and acetylcholine, respectively. Endothelial morphology and nitric oxide synthase (eNOS) levels were determined by histology analysis.
RESULTS: Endothelial-dependent vasorelaxation (bradykinin) was significantly reduced by 52, 87, and 97% in the pig coronary artery rings treated with 10, 50, and 100 microM homocysteine, respectively, compared to controls (P < 0.05). There were no differences in endothelium-independent vasorelaxation (sodium nitroprusside) or in smooth muscle contractility (U46619) between control and homocysteine-treated groups (P > 0.05). Acetylcholine-induced vasorelaxation was also significantly reduced by 44 and 98% in the pig carotid arteries treated with 50 and 100 microM homocysteine, respectively, compared to controls (P < 0.05). Variable degrees of endothelial cell injury, such as morphology change and detachment, were observed, and eNOS immunoreactivity was markedly reduced in both pig coronary and carotid arteries that were treated with high doses of homocysteine.
CONCLUSION: These data demonstrated that homocysteine significantly decreased endothelium-dependent vasorelaxation and eNOS immunoreactivity as well as induced marked endothelial injury in both porcine coronary and carotid arteries. This study suggests that homocysteine-mediated endothelial dysfunction and injury may play important roles in vascular lesion formation in the hyperhomocysteinemic patient. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792147     DOI: 10.1006/jsre.2001.6304

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  15 in total

1.  Mesenteric vascular remodeling in hyperhomocysteinemia.

Authors:  C Munjal; S Givvimani; N Qipshidze; N Tyagi; J C Falcone; S C Tyagi
Journal:  Mol Cell Biochem       Date:  2010-11-13       Impact factor: 3.396

Review 2.  Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia.

Authors:  Dorothea Rosenberger; Karni S Moshal; Ganesh K Kartha; Neetu Tyagi; Utpal Sen; David Lominadze; Claudio Maldonado; Andrew M Roberts; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2006 Oct-Dec       Impact factor: 4.076

3.  Rheolytic pharmacomechanical thrombectomy in experimental chronic deep vein thrombosis: effect of L-arginine on thrombogenicity and endothelial vasomotor function.

Authors:  Peter H Lin; Tamuru Okada; James L Steinberg; Wei Zhou; Hosam F El Sayed; Anish Rawat; Panos Kougias; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

4.  Homocysteine stimulates inducible nitric oxide synthase expression in macrophages: antagonizing effect of ginkgolides and bilobalide.

Authors:  Connie W H Woo; Filly Cheung; Vincent W H Chan; Yaw L Siow; Karmin O
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

5.  Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes.

Authors:  H C Looker; A Fagot-Campagna; E W Gunter; C M Pfeiffer; K M Venkat Narayan; W C Knowler; R L Hanson
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

6.  Growth hormone-releasing peptide ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells.

Authors:  Nasim Hedayati; Suman Annambhotla; Jun Jiang; Xinwen Wang; Hong Chai; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  J Vasc Surg       Date:  2008-11-22       Impact factor: 4.268

Review 7.  Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID).

Authors:  Atticus H Hainsworth; Natalie E Yeo; Erica M Weekman; Donna M Wilcock
Journal:  Biochim Biophys Acta       Date:  2015-12-09

8.  Homocysteine alters vasoreactivity of human internal mammary artery by affecting the KCa channel family.

Authors:  Wen-Tao Sun; Hong-Mei Xue; Hai-Tao Hou; Huan-Xin Chen; Jun Wang; Guo-Wei He; Qin Yang
Journal:  Ann Transl Med       Date:  2021-04

9.  Effects of red grape juice consumption on high density lipoprotein-cholesterol, apolipoprotein AI, apolipoprotein B and homocysteine in healthy human volunteers.

Authors:  Mohammad H Khadem-Ansari; Yousef Rasmi; Fatemeh Ramezani
Journal:  Open Biochem J       Date:  2010-12-15

10.  Mitochondrial mitophagy in mesenteric artery remodeling in hyperhomocysteinemia.

Authors:  Anastasia Familtseva; Anuradha Kalani; Pankaj Chaturvedi; Neetu Tyagi; Naira Metreveli; Suresh C Tyagi
Journal:  Physiol Rep       Date:  2014-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.